Christopher Walpole

2.1k total citations · 1 hit paper
29 papers, 1.6k citations indexed

About

Christopher Walpole is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Christopher Walpole has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 8 papers in Physiology. Recurrent topics in Christopher Walpole's work include Neuropeptides and Animal Physiology (9 papers), Pharmacological Receptor Mechanisms and Effects (8 papers) and Pain Mechanisms and Treatments (7 papers). Christopher Walpole is often cited by papers focused on Neuropeptides and Animal Physiology (9 papers), Pharmacological Receptor Mechanisms and Effects (8 papers) and Pain Mechanisms and Treatments (7 papers). Christopher Walpole collaborates with scholars based in Canada, Japan and United Kingdom. Christopher Walpole's co-authors include Stuart Bevan, Iain F. James, Roger Wrigglesworth, Glyn A. Hughes, H P Rang, Sandeep S Hothi, J.C. Yeats, Kirti Shah, Janet Winter and Andy Dray and has published in prestigious journals such as FEBS Letters, Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

Christopher Walpole

29 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin

1992 510 citations Stuart Bevan, Sandeep S Hothi et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Walpole Canada	17	841	584	553	477	209	29	1.6k
Michael E. Kort United States	22	539 0.6×	414 0.7×	453 0.8×	332 0.7×	296 1.4×	36	1.6k
Sonya G. Lehto United States	20	623 0.7×	494 0.8×	470 0.8×	455 1.0×	110 0.5×	28	1.5k
Charles A. Blum United States	12	490 0.6×	294 0.5×	350 0.6×	160 0.3×	239 1.1×	17	1.2k
Heath A. McDonald United States	18	566 0.7×	264 0.5×	462 0.8×	213 0.4×	130 0.6×	23	1.0k
Glyn A. Hughes Sweden	6	486 0.6×	318 0.5×	310 0.6×	217 0.5×	76 0.4×	6	831
Bruce R. Bianchi United States	17	412 0.5×	356 0.6×	346 0.6×	299 0.6×	96 0.5×	32	1.1k
Harshad K. Rami United Kingdom	16	390 0.5×	265 0.5×	302 0.5×	116 0.2×	154 0.7×	24	854
Bernard Bucher France	18	130 0.2×	676 1.2×	357 0.6×	527 1.1×	55 0.3×	38	1.5k
Mervyn Thompson United Kingdom	21	202 0.2×	387 0.7×	212 0.4×	213 0.4×	469 2.2×	44	1.1k
Bilal Çiğ Türkiye	23	355 0.4×	350 0.6×	277 0.5×	110 0.2×	48 0.2×	31	1.3k

Countries citing papers authored by Christopher Walpole

Since Specialization

Citations

This map shows the geographic impact of Christopher Walpole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Walpole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Walpole more than expected).

Fields of papers citing papers by Christopher Walpole

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Walpole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Walpole. The network helps show where Christopher Walpole may publish in the future.

Co-authorship network of co-authors of Christopher Walpole

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Walpole. A scholar is included among the top collaborators of Christopher Walpole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Walpole. Christopher Walpole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Yun‐Xing, Mehrnaz Pourashraf, Xuehong Luo, et al.. (2012). γ-Carbolines: A novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration. Bioorganic & Medicinal Chemistry Letters. 22(4). 1619–1624. 13 indexed citations

Wei, Zhongyong, Hua Yang, Ziping Liu, et al.. (2012). N-Methyl-3-(tetrahydro-2H-pyran-4-yl)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamides as a novel class of cannabinoid receptors agonists with low CNS penetration. Bioorganic & Medicinal Chemistry Letters. 22(12). 3884–3889. 3 indexed citations

Cantin, Louis‐David, Malken Bayrakdarian, Eric Grazzini, et al.. (2012). Discovery of P2X3 selective antagonists for the treatment of chronic pain. Bioorganic & Medicinal Chemistry Letters. 22(7). 2565–2571. 26 indexed citations

Pagé, Daniel, Zhongyong Wei, Ziping Liu, et al.. (2010). 5-Sulfonamide Benzimidazoles: A Class of Cannabinoid Receptors Agonists with Potent In Vivo Antinociception Activity. Letters in Drug Design & Discovery. 7(3). 208–213. 12 indexed citations

Jones, Paul A., Andrew M. Griffin, Lars Gawell, et al.. (2009). N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: The development of diaryl amino piperidines as potent δ opioid receptor agonists with in vivo anti-nociceptive activity in rodent models. Bioorganic & Medicinal Chemistry Letters. 19(21). 5994–5998. 12 indexed citations

Griffin, Andrew M., et al.. (2009). Delta agonist hydroxy bioisosteres: The discovery of 3-((1-benzylpiperidin-4-yl){4-[(diethylamino)carbonyl]phenyl}amino)benzamide with improved delta agonist activity and in vitro metabolic stability. Bioorganic & Medicinal Chemistry Letters. 19(21). 5999–6003. 7 indexed citations

Dockendorff, Chris, Shujuan Jin, Madeline Olsen, et al.. (2008). Discovery of μ-opioid selective ligands derived from 1-aminotetralin scaffolds made via metal-catalyzed ring-opening reactions. Bioorganic & Medicinal Chemistry Letters. 19(4). 1228–1232. 26 indexed citations

Walpole, Christopher, Michael C. Brown, Iain F. James, et al.. (1998). Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK₁ receptor antagonist. British Journal of Pharmacology. 124(1). 83–92. 15 indexed citations

Campbell, Elizabeth A., et al.. (1998). Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of neuropathic pain in the guinea-pig. Neuroscience. 87(3). 527–532. 33 indexed citations

10.

Walpole, Christopher, Stuart Bevan, Robin J. Breckenridge, et al.. (1994). The Discovery of Capsazepine, the First Competitive Antagonist of the Sensory Neuron Excitants Capsaicin and Resiniferatoxin. Journal of Medicinal Chemistry. 37(13). 1942–1954. 174 indexed citations

11.

Walpole, Christopher, Roger Wrigglesworth, Stuart Bevan, et al.. (1993). Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 3. The hydrophobic side-chain "C-region". Journal of Medicinal Chemistry. 36(16). 2381–2389. 82 indexed citations

12.

Walpole, Christopher, Roger Wrigglesworth, Stuart Bevan, et al.. (1993). Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 2. The amide bond "B-region". Journal of Medicinal Chemistry. 36(16). 2373–2380. 70 indexed citations

13.

Walpole, Christopher, Roger Wrigglesworth, Stuart Bevan, et al.. (1993). Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic "A-region". Journal of Medicinal Chemistry. 36(16). 2362–2372. 133 indexed citations

14.

Winter, J., Christopher Walpole, Stuart Bevan, & Iain F. James. (1993). Characterization of resiniferatoxin binding sites on sensory neurons: Co-regulation of resiniferatoxin binding and capsaicin sensitivity in adult rat dorsal root ganglia. Neuroscience. 57(3). 747–757. 45 indexed citations

15.

Maggi, C.A., Stuart Bevan, Christopher Walpole, H P Rang, & Sandro Giuliani. (1993). A comparison of capsazepine and ruthenium red as capsaicin antagonists in the rat isolated urinary bladder and vas deferens. British Journal of Pharmacology. 108(3). 801–805. 72 indexed citations

16.

Bevan, Stuart, Sandeep S Hothi, Glyn A. Hughes, et al.. (1992). Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. British Journal of Pharmacology. 107(2). 544–552. 510 indexed citations breakdown →

17.

Walpole, Christopher, et al.. (1990). Immunochemical detection of photoaffinity‐labelled capsaicin‐binding proteins from sensory neurons. FEBS Letters. 269(2). 381–385. 17 indexed citations

18.

Dray, A., et al.. (1990). NE-19550 and NE-21610, antinociceptive capsaicin analogues: studies on nociceptive fibres of the neonatal rat tail in vitro. European Journal of Pharmacology. 181(3). 289–293. 39 indexed citations

19.

Walpole, Christopher & Roger Wrigglesworth. (1989). Enzyme inhibitors in medicine. Natural Product Reports. 6(4). 311–311. 16 indexed citations

20.

James, Iain F., et al.. (1988). Long-lasting agonist activity produced by a capsaicin-like photoaffinity probe.. Molecular Pharmacology. 33(6). 643–649. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact